Advances in the management of malignant glinoma recurrence

Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 7

Abstract

Since virtually all malignant gliomas relapse after primary treatment the management of relapsing glioma is a common clinical dilemma. Before making a decision on choice of surgery, chemotherapy or radiotherapy as a treatment option one should consider additional imaging studies to exclude nonmalignant lesions such as radiation necrosis. Standard CT and NMR studies are not sufficient in this context and should be supplemented with NMR spectroscopy, PET, SPET, etc. Secondary surgery should be considered in patients in good shape, with relapse localized in the previously irradiated area. Chemotherapy based on nitrosurea or temozolomide may prolong the patient’s life and improve its quality in selected patients. The emergence of molecular profiling has made it possible to select patients with higher chances of responding to chemotherapy. New targeted therapies inhibiting signal transduction through EGFR, interfering with angiogenesis and other molecules which have been developed on the basis of the expanding knowledge of glioma molecular progression pathways are being studied in clinical trials. Radiotherapy used in the management of relapsing glioma should be highly conformal and include brachytherapy, stereotactic radiotherapy and IMRT conformal radiotherapy. New functional imaging studies are opening exciting possibilities of modulation of radiation dose in relation to hypoxia, angiogenesis area, etc.

Authors and Affiliations

Sergiusz Nawrocki

Keywords

Related Articles

Squamous cell carcinoma antigen (SCC) in diagnostics and monitoring treatment of patients with cervical cancer

Squamous cell carcinoma antigen (SCC) is the first marker of squamous cell carcinoma and a member of the serin proteinase inhibitor family. Increased concentration of SCC occurs in squamous cancers of the region of the h...

Results of treatment and analysis of prognostic factors in adult patients with Ewing's sarcoma at the material of Center of Oncology in Cracow

Aim: The aim of this study is to present the results of treatment of Ewing’s sarcoma in adults at the Centre of Oncology in Cracow between 1970 and 2001. Materials and methods: There was a group of 25 adult patients: 19...

Screening in colorectal cancer (CRC)

Colorectal cancer (CRC) is one of major health problems in Poland. Every year about 11 000 new cases of CRC (EU about 220 000) are diagnosed; the number of deaths approaches 8 000 (EU 112 000). Five-year free disease sur...

Antygen raka płaskonabłonkowego (SCC) w diagnostyce i monitorowaniu leczenia chorych na raka szyjki macicy

Antygen raka płaskonabłonkowego (SCC – squamous cell carcinoma antigen) jest pierwszym markerem w raku szyjki macicy. SCC należy do rodziny inhibitorów proteaz serynowych. Podwyższone stężenie SCC występuje w rakach pł...

Download PDF file
  • EP ID EP154629
  • DOI -
  • Views 90
  • Downloads 0

How To Cite

Sergiusz Nawrocki (2006). Advances in the management of malignant glinoma recurrence. Współczesna Onkologia, 10(7), 334-339. https://www.europub.co.uk/articles/-A-154629